Sonic Healthcare (ASX:SHL) share price on watch after 149% profit boost in FY21

After rallying 30% year-to-date, Sonic Healthcare share price will be put to the test after the release of the company’s FY21 results.
The post Sonic Healthcare (ASX:SHL) share price on watch after 149% profit boost in FY21 appeared first on The Motley Fool Australia. –

The Sonic Healthcare Limited (ASX: SHL) share price will be in the spotlight on Monday after the company released its FY21 full-year results this morning.

Sonic Healthcare share price in focus after bumper profit result

The Sonic Healthcare share price could be a mover following a well-rounded financial performance in FY21. Key highlights include:

Revenue of $8.8 billion, up 28% on the prior corresponding period (pcp).

Earnings before interest, taxes, depreciation, and amortisation (EBITDA) surged to $2.6 billion, up 81%.
Net profit rocketed to $1.3 billion, up 149%.
Final dividend of 55 cents, up 8%.
Full year FY21 dividend of 91 cents, up 7%.

What happened for Sonic Healthcare in FY21?

The Sonic Healthcare share price has rallied strongly in FY21, thanks to its resilient base business and active role in combating the COVID-19 pandemic.

The company has performed approximately 30 million COVID-19 PCR tests to date across ~60 Sonic laboratories globally.

The results noted that COVID-19 PCR volumes were lower in the second half of the year versus the first half, but have been increasing post-year end with the spread of the Delta variant.

Its base business revenue (excluding COVID testing) grew 6% compared to FY20 and was up 4% versus FY19.

Sonic Healthcare’s EBITDA surged 81%, again enhanced by COVID-19 testing and leveraging existing infrastructure. The company’s laboratory businesses across ANZ, USA and Europe contribute approximately 88% of Group revenues, and the company was pleased to highlight a significant improvement in EBITDA margins

EBITDA margins for its Laboratory division increased from 21.3% to 30.8%. At the same time, Sonic Healthcare’s medical imaging business reported 24% EBITDA growth and 108 basis points of margin improvement.

Management commentary

Sonic Healthcare’s CEO Dr Colin Goldschmidt commented on the results, saying:

As a global healthcare organisation, we have continued to play a major role in combating the COVID19 pandemic, by providing 30 million PCR tests and over 2 million serology tests to date. We are also proud to be the largest non-government provider of COVID-19 vaccinations in Australia.

Goldschmidt also shed light on the company’s strategic focus on acquisitions:

In addition to organic growth, Sonic continues to focus on synergistic acquisitions and other growth opportunities, supported by our current record low gearing levels, geographic footprint, leading market positions and brands, and our deeply embedded Medical Leadership culture. We were delighted to recently announce the pending acquisition of Canberra Imaging Group, following on from our move in March 2021 to majority ownership of Epworth Medical Imaging. We are actively considering further acquisition opportunities, as well as bidding for a number of outsourcing contracts.

What’s next for Sonic Healthcare?

The Sonic Healthcare share price has rallied strongly this year, up 30% year-to-date.

The company advised that it will not provide earnings guidance for FY22 due to COVID-19 related unpredictability:

“The pandemic has the potential to cause fluctuations in both COVID-19 testing revenues and the base business, although the base business has become increasingly resilient to the impacts of pandemic waves. The underlying growth drivers for healthcare services remain unchanged. Base business fluctuations are also mitigated by geographical and business sector diversity. The COVID-19 Delta variant is currently driving increases in COVID-19 testing revenues.”

The post Sonic Healthcare (ASX:SHL) share price on watch after 149% profit boost in FY21 appeared first on The Motley Fool Australia.

Should you invest $1,000 in Sonic Healthcare right now?

Before you consider Sonic Healthcare, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sonic Healthcare wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

More reading

5 things to watch on the ASX 200 on Monday

How did the Sonic Healthcare (ASX:SHL) share price respond last earnings season?
2 high quality ASX dividend shares named as buys

2 ASX 200 shares that could be buys for growth

2 excellent ASX 200 blue chip shares named as buys

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!